Geode Capital Management
SNTI icon

Geode Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Geode Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
207,043
+62,246
+43% +$60.2K ﹤0.01% 3976
2025
Q4 		$151K Sell
144,797
-8,041
-5% -$14.2K ﹤0.01% 3997
2025
Q3 		$216K Buy
152,838
+5,524
+4% +$9.23K ﹤0.01% 3900
2025
Q2 		$311K Buy
147,314
+117,588
+396% +$372K ﹤0.01% 3722
2025
Q1 		$99.9K Buy
29,726
+2,232
+8% +$8.69K ﹤0.01% 4031
2024
Q4 		$96.5K Buy
27,494
+201
+0.7% +$642 ﹤0.01% 4106
2024
Q3 		$61.7K Buy
27,293
+2,734
+11% +$7.22K ﹤0.01% 4221
2024
Q2 		$67.8K Hold
24,559
– – ﹤0.01% 4222
2024
Q1 		$92.6K Buy
24,559
+718
+3% +$3.21K ﹤0.01% 4183
2023
Q4 		$157K Hold
23,841
– – ﹤0.01% 4022
2023
Q3 		$101K Buy
23,841
+3,822
+19% +$26.3K ﹤0.01% 4246
2023
Q2 		$125K Hold
20,019
– – ﹤0.01% 4248
2023
Q1 		$236K Hold
20,019
– – ﹤0.01% 3960
2022
Q4 		$282K Buy
20,019
+3,291
+20% +$80.3K ﹤0.01% 3923
2022
Q3 		$362K Buy
16,728
+13,916
+495% +$274K ﹤0.01% 3900
2022
Q2 		$55K Hold
2,812
– – ﹤0.01% 4754
2022
Q1 		$277K Sell
2,812
-955
-25% -$94.3K ﹤0.01% 4217
2021
Q4 		$371K Buy
3,767
+351
+10% +$35K ﹤0.01% 4192
2021
Q3 		$339K Hold
3,416
– – ﹤0.01% 4206
2021
Q2 		$339K Buy
+3,416
New +$341K ﹤0.01% 4109

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Geode Capital Management's SNTI Position: Q1 2026 in Review

Geode Capital Management increased its Senti Biosciences Holdings (SNTI) stake by 43% in Q1 2026, buying an estimated $60.2K and bringing the position to 207,043 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #3976.

Geode Capital Management first reported a position in SNTI in Q2 2021 and has held it in 20 quarters since. The position peaked at $371K in Q4 2021. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • Geode Capital Management held 207,043 shares of Senti Biosciences Holdings worth $168K as of Q1 2026.
  • Geode Capital Management bought 62,246 Senti Biosciences Holdings shares in Q1 2026, an estimated $60.2K.
  • Senti Biosciences Holdings made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3976 holding.
  • Geode Capital Management first reported a position in Senti Biosciences Holdings in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Senti Biosciences Holdings position peaked at $371K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.